Skip to main content
Fig. 5 | BMC Immunology

Fig. 5

From: Comprehensive analysis of immunoglobulin and clinical variables identifies functional linkages and diagnostic indicators associated with Behcet’s disease patients receiving immunomodulatory treatment

Fig. 5

Comprehensive analysis of pathological and pharmacological linkages in BD patients receiving immunomodulatory therapy. a. Heatmap of pathological linkages; b. The correlation changes in representative pathological linkages (A/G-MCH and A/G-MCHC) in HCs and BD patients without and with immunomodulatory therapy; c. The plot analysis of A/G-MCH correlations in HC and BD patients without and with immunomodulatory therapy; d. Heatmap of pharmacological linkages; e. The correlation changes in representative pharmacological linkages (CRP-PA, ESR-PA and CRP-Alb) in HCs and BD patients without and with immunomodulatory therapy; f. The plot analysis of CRP-PA correlations in HCs and BD patients without and with immunomodulatory therapy. HC: healthy control; BD: Behcet’s disease

Back to article page